In about half of all cases of choriocarcinoma and 10 to 15% of invasive mole the antecedent pregnancy is hydatidiform mole. Regardless the method of termination close follow up with serial beta HCG titer is essential for every patient because the incident of malignant disease commonly thought to be 20-30% and the cure rate of properly treated metastatic gestational trphoblastic neoplasia is approximately 90% 1 . This trophoblastic disease has got a wide range of complications. It may be persistent resulting metastatic or nonmetastatic malignant disease and may recur in subsequent pregnancy.
Molar pregnancy occur most frequently in South East
Asia like Malaysia, Singapore, Hong Kong, Indonesia, Philippines and China 2 . Incidence in Philippines is 1 in 80,in India is1 in 400 3 . The exact etiology of the disease is yet unknown, but it appears to be related to the ovular defect as it some times affects one ovum of a twin pregnancy. There is an increased risk in teenagers and woman over 35 years. The rate rises to 10 fold after the age of 40 years 1 . Patients with higher parity are at higher risk in under developed countries 4 . No parity effect was found in two studies 3 . It occurs especially in rice eater and in those whose diets are deficient in protein, folic acid and carotene. The occurrence of a trophoblastic tumor can be regarded as the result of a breakdown in what must be a complicated host invader balance. There are also reports of matching leucocytic HLA types between the woman and her partner.The lack of ability to control trophoblastic activity has two possible basis an inherent or immunological one and one which results from malnutrition and debility.Gestational trophoblastic tissue may suppress the maternal immune response via such factors as interleukins and tumor necrosis factor.Rise of gamma globulin level in absence of hepatic disease.Increase association of ABO blood group which possesses an ABO antigen 2 .
Clinical Presentation and Management of Hydatidiform Mole in a Peripheral Tertiary Hospital
The symptom which most often calls attention to the abnormality is recurrent uterine bleeding. Nausea, vomiting have been reported in 14-32 % of patients of hydatidiform mole and may be confused with nausea and vomiting of early pregnancy. In over 80% of cases the first evidence of hydatidiform mole is the passage of vesicular tissue, bleeding and brown discharge.
The uterus is too large for the period of amenhorrea. is present in only 50% of cases .Sometimes the uterus is smaller than normal, especially if the mole dies. Enlargement of both ovaries seen in 25-30% of molar pregnancy. Suction evacuation and curettage is the preferred method of choice regardless of uterine size. When a large hydatidiform mole (>12wks size) is evacuated by suction curettage a laparatomy set up should be readily available as hysterotomy, hysterectomy, or bilateral hypogastric artery ligation may be necessary if perforation or hemorrhage occur 1. .In all cases even if the mole has been removed by hysterectomy regular observation of patient is essential to detect the first sign of remaining or reawakening chorionic activity 3. Follow up is done with serial beta HCG estimation ,gynecological examination & Chest radiography. Approximately 70% patients develop a normal beta HCG within 8 weeks post evacuation. Another 15% demonstrate continuous decline in titer and ultimately achieve normal titer without treatment . Rest 15% who have elevated titer at 8 weeks postevaquation demonstrates rising titer or platue . Nearly half of these patients will have histological evidence of invasive mole and the other half will have choriocarcinoma. Therefore the required sample size n = 384, but due to the reduced patient attendant it was not possible to collect required number of sample. After fulfillment of eligibility criteria 50 cases were collected during the study period. Sampling technique was purpusive consecutive sampling. Without any complications 4 8
Materials and Methods

Measurement of out Come
Seventy two percent (36) patients received first line treatment with suction evacuation& curettage, 12 (24%) patients were treated by D&C due to incomplete evacuation earlier and 2 patients needed laparatomy followed by hysterectomy due to uterine perforation (table-4). Among 50 patients 28% had incomplete evacuation and 14% developed shock and4% had uterine perforation managed by resuscitation by blood transfusion followed by laparatomy and hysterectomy (table -5). In this study 64% of patients appeared for regular follow up for one years.20% appeared irregularly and 16% dropped out. (Table-6 ). 
Discussion:
In this study the incidence of molar pregnancy was 8.27 per thousand pregnancies that is 1 in 121 pregnancies .Study by Nahar (20005-2006) in FMCH &BSMMU showed incidence of molar pregnancy to be 1 in 141 pregnancy that is 7.08 per thousand pregnancy 6 . Another study by Khatoon RA 1993 in DMCH it was found that the incidence was 1 in 107 pregnancies e.g. 9.3 per thousand 7 . Study by Akhter 1978-1980 at SSMC and Mitford Hospital showed that incidence of molar pregnancy was 1 in 144 delivery that is 6.9 per thousand 8 . Study by Mungan E. 1996 showed much lower incidence 1.84 per thousand pregnancies 9 . Another study in India by Reddy and Rajeswari during 1989-91 showed an incidence of 4.08 per thousand pregnancies 10 . In this study maximum number of patients (60%) were in 20-29 yrs age group . Study by Nahar (2005 Nahar ( -2006 at FMCH & BSMMU showed that 64% patients were in 20-29 yrs age group 6 . A study by Khatoon RA in 1993 at DMCH showed that 63.75% patients were in 21-30 yrs age group 7 . Another study of 287 patients was done in Pusan, Korea 11 which showed highest number patients (70%) were below 30 yrs of age. In a study of 38 cases from the department of Obstetrics and Gynecology, Pennsylvenia Hospital, maximum (60%) patient was between 20-30 years. Findings of this study are comparable of the previous ovservations .In present series most of the patients (60%) were multipara. also a large percentage (40%) of patients were nulliparous .
The study of 50 cases of GTD at Triput Maternity Hospital India by Reddy and Rajeshwari showed that 70% patients were of 1-3 parity where as the study of 310 cases by Mungan et al (1996) differ from present study in that multiparty was found to be strongly associated with hydatidiform mole in 60% cases. So findings of present study were consistent with other study but it differed from the study by Mungan et al (1996) 9 .
In present series most of the patients with molar pregnancy had blood group B (36%).In the study of Nahar most of the patients with molar pregnancy had blood group A (32%).The study of Reddy and Rageshwary (1994) showed 52% of molar pregnancy patients had blood group O. Study by Nahar in FMCH & BSMMU Hospital (2005) (2006) showed abnormal vaginal bleeding and amenorrhea were the commonest (60%) complaints 6 . According to Gold Stein DP, Berkowitz RS (1994) the most common presenting symptom in patients was bleeding (97%) 13 . A study by Curry SL from North Carolina USA of 347 patients 89% of patients had abnormal bleeding 14 . In this study (Table-1 ) 60% patients presented with abnormal vaginal bleeding with amenorrhea,16% presented in addition with passage of vesicles, 4% of patients were diagnosed accidentally by USG and had no symptom except amenorrhea.
Out of 50 patients 46% patients were at 12-16 weeks of gestation at the time of admission (Table-2) which is consistent with the study of Nahar with (40%) patients with 12-16 weeks of gestation at admission 6 . No patients presented beyond 24 weeks and 26% patients presented before 12 weeks in this series. In the present study diagnosis was confirmed by USG 72% and pre evacuation serum beta HCG in (20%), 4% was diagnosed by USG without any symptom. Histopathology was done for all patients .
Most of the patients (80%) in this series came with hemorrhage as the immediate complication, 8% presented with shock 4% presented with no complication, no patient presented with preeclampsia.In Nahar study 80% presented with hemorrhage as immediate complication,12% presented with shock, no patients had preeclampsia.A study of 327 patients by curry S.L. from North Carolina showed that 80% had abnormal uterine bleeding.12% developed preeclampsia.So our study correlates with both the studies in that maximum presentation was as hemorrhage as immediate complication, but other severe complication like shock is comparatively low in this series probably because of early presentation &early intervention than previous which can also explain that some patient also had no complication at diagnosis.
Among the treated patients 14(28%) patient had incomplete evacuation and treated with D&C .Seven (14%) patients developed shock and managed with blood transfusion and other measures. Two (4%) patient had uterine perforation and had laparatomy followed by hysterectomy (Table-4) .Among the three patients (6%) who developed persistent mole (Table-7 ) had no evidence of metastasis. Two of them were treated with chemotherapy and one was treated with total abdominal hysterectomy. One patient (2%) who attended no follow up developed choriocarcinoma and presented with severe anemia & lung metastasis and died. Follow up of the patients were done by clinical examination, serum beta HCG, X-ray chest (where indicated) and USG (where indicated) for a period of 1 year. In this series ( Table-6 ) 32(64%) patients of GTD attended for regular follow up, 20% had irregular follow up,16% had dropped out . In the study of Nahar Shamsun 70% patients attended for regular follow up, and 30% dropped out. In her study no patient had attended irregularly for follow up.
Thirty (60%) patients were cured by 6-8 weeks,6% developed persistent mole which was evidenced by persistently increasing or pleatu of beta HCG and 2% developed choriocarcinoma which was evidenced by presence of pulmonary metastasis and increasing or raised level of beta HCG. In comparison to Nahar study (2005) (2006) in FMCH and BSMMU that showed 8.55% patients developed persistent mole and 5.7% patients developed choriocarcinoma, but cure rate was similar. In Boston 23% patients developed persistent trophoblastic disease 16 and in Ankara Turkey (1996) 14.5% patients were diagnosed as persistent molar disease 9 .
Conclusions:
Incidence of GTDs in FMCH was 8.27 per thousand pregnancies, more common in multiparous women of low socioeconomic class and in B+ve blood group women. Incidence in nulliparous is also high.Maximum patients presented at 12-16 weeks of gestation with abnormal vaginal bleeding. Seventy two percent patients were treated with suction evacuation and curettage. Hemorrhage was most common complication .During one year of surveillance period 64% patients attended the follow up protocol regularly, 20% had irregular follow up and16% dropped out . The incidence of Persistent Gestational Trophoblastic Disease(GTD) was 6% and choriocarcinoma was 2%. It seems that attendants for follow up can be raised by proper counseling and raising awareness of the patients. As prognosis of persistent GTD can only be improved by early diagnosis of the cases and by early administration of chemotherapeutic agents, only way to save these women by regular follow up. That is only possible by raising awareness and counseling.
